Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962362 · ClinicalTrials.gov registry record
Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty
A clinical trial, sponsored by Exactech.
- Terminated
- Registry status
- 73
- Enrollment target
NCT02962362 is a clinical trial that was terminated before completion, run by Exactech. The registered enrollment target is 73 participants.
The verdict
NCT02962362 was terminated before completion, sponsored by Exactech.
- TERMINATED
- Registry status
- 73 participants
- Enrollment target
Study Summary
Study to collect outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2016-08 |
| Est. Completion | 2021-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02962362
The ClinicalTrials.gov registry entry for NCT02962362 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exactech, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02962362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02962362 about?
NCT02962362 is a clinical study titled "Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty". Study to collect outcomes data for patients who are undergoing an Exactech Optetrak® primary total knee replacement using the Exactech Guided Personalized Surgery (eGPS®) manufactured or distributed by (Exactech, Gainesville, Florida, USA).
What is the current status of trial NCT02962362?
This trial is currently terminated. The enrollment target is 73 participants. The study started on 2016-08. Estimated completion is 2021-11.
Who is sponsoring clinical trial NCT02962362?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.